Michelle Baxter
About
In The Last Decade
Michelle Baxter
4 papers receiving 602 citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Oncology 431
- Molecular Biology 283
- Pulmonary and Respiratory Medicine 191
- Radiology, Nuclear Medicine and Imaging 147
- Organic Chemistry 90
Countries citing papers authored by Michelle Baxter
This map shows the geographic impact of Michelle Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Baxter more than expected).
Fields of papers citing papers by Michelle Baxter
This network shows the impact of papers produced by Michelle Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Baxter. The network helps show where Michelle Baxter may publish in the future.
Co-authorship network of co-authors of Michelle Baxter
This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Baxter. A scholar is included among the top collaborators of Michelle Baxter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Baxter. Michelle Baxter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 18 | |
| 3 | Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase breakdown → | 503 |
| 4 | HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. | 97 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.